3M 8-K

Summary

PFAS personal-injury settlement. 3M agreed to resolve claims focused on the aqueous film-forming foam (AFFF) multidistrict litigation involving per- and polyfluoroalkyl substances (PFAS); the settlement is designed to address approximately 99% of current personal-injury claims inside and outside the litigation, covering 115,000–120,000 eligible plaintiffs. 3M says the settlement substantially reduces litigation uncertainty; participation thresholds must be met, and claimants must enroll and release covered claims.

Key Figures

• Settlement commitment: $7.35B nominal from 2026 through 2034, with a present value of $5.8B. 3M will record a $5.8B pre-tax charge in Q4 2026 as a special item; that is approximately 3.7x its $1.56B operating income for Q3 FY2026 (10-Q, 9/30/2026).
• Payment schedule includes $50M in 2026 and no payments in 2027; approximately 20% of payments are due in the final two years. The total commitment includes a $680M reserve fund, and actual amounts and payment dates depend on claimant participation thresholds.
• Remaining and future claims are to be managed through payments contingent on claimants joining the settlement and an anticipated court order setting evidentiary and timing requirements for plaintiffs who may litigate in the future. The settlement is not an admission of liability.

Guidance

• 2026 guidance reaffirmed; figures not restated in this filing.